19th Edition Project Portfolio and Resource Management Excellence for Pharma and Biotech

The Pharma Portfolio Management Conference by Marcus Evans is an important industry event for those working in pharmaceutical project and portfolio management. The conference brings together senior executives of the top players in the pharmaceutical industry to deliberate on issues like driving value from the drug portfolio, optimising R&D spend, and more importantly, dealing with changing dynamics of the pharmaceutical business. The purpose of this event is to present the industry professionals with information on how to meet these challenges while also considering the potential for profit in a highly competitive field.

Conference topics of interest will include where to best focus R&D dollars for new antibiotics, how different investment portfolios with different risks can be effectively managed, and how product and strategic plans should be developed and modified to reflect new trends and regulations. The attendees will also be able to learn how they can follow the movements of the market and integrate it into their portfolio management ideologies in order to capture the fast-growing market for cheaper treatments. Industry thought leaders will discuss concrete examples, industry benchmarks, and business solutions to enhance the value of a portfolio while ensuring outstanding levels of compliance and quality.

The other aspect that stands out from the rest of the event is the chance to work together with other people. Pharmaceutical R&D managers, project/program managers and directors, business development directors and managers, and finance managers and directors appointed at a senior level will be given the opportunity to discuss best practices and approaches for dealing with the issues in portfolio management. Panel sessions and workshops will offer participants precise knowledge on the company’s matters related to PPM and the main strategies for success in their organizations. Reasons for attending This event is crucial to the pharmaceutical leaders who want to stay afloat in very competitive environment and make their portfolios sustainable.